Boehringer Ingelheim: Renal Insufficiency, Chronic trials
The registry lists 13 Renal Insufficiency, Chronic studies with Boehringer Ingelheim as lead sponsor. 0 are open to participants now and 7 have results posted.
Phase 1 2Phase 2 5Phase 3 3No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD)CompletedNCT06287073Results posted
- A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental GlomerulosclerosisCompletedNCT05213624Phase 2Results posted
- A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney DiseaseCompletedNCT05182840Phase 2Results posted
- A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney DiseaseTerminatedNCT04881448Phase 2Results posted
- A Study to Test the Effect of Different Doses of Avenciguat (BI 685509) on Kidney Function in People With Chronic Kidney DiseaseCompletedNCT04736628Phase 2Results posted
- EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)CompletedNCT03594110Phase 3Results posted
- Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.CompletedNCT01711853Phase 1Results posted
- A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)Active, not recruitingNCT07107945Phase 3
- SGLT2 Inhibitors and Renal Anemia in Japan: RWDActive, not recruitingNCT07063316
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney DiseaseCompletedNCT06926660Phase 2
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)Active, not recruitingNCT06531824Phase 3
- Post Marketing Surveillance of JARDIANCE in Chronic Kidney DiseaseActive, not recruitingNCT06527846
- A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 764198 is Processed in the BodyCompletedNCT04176536Phase 1